Physician profile
Michael Healy
NPI 1861495020
$863.07
in general payments reported to CMS, 2019-2025
10 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $21.05 · 2022: $30.40 · 2023: $41.00 · 2024: $18.26 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $349 · Food and Beverage: $171 · Education: $13.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $349.20 |
| Food and Beverage | $171.35 |
| Education | $13.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $474.89 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Amgen INC. | $161.66 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $49.32 | 2019 | |
| Opko Pharmaceuticals, LLC | $44.53 | 2019-2020 | |
| Inari Medical, INC. | $30.40 | 2022 | |
| Medtronic, INC. | $27.40 | 2023 | Corevalve Evolut R |
| Mallinckrodt Enterprises LLC | $25.06 | 2019 | |
| Abbott Laboratories | $18.26 | 2024 | Mitraclip |
| Akebia Therapeutics INC | $17.95 | 2019 | |
| Calliditas Therapeutics US INC. | $13.60 | 2023 | Tarpeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Healy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.